A detailed history of Alyeska Investment Group, L.P. transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 1,083,333 shares of GRTS stock, worth $21,666. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,083,333
Holding current value
$21,666
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.62 - $2.35 $2.15 Million - $8.13 Million
3,461,489 New
3,461,489 $2.15 Million
Q3 2018

Nov 14, 2018

BUY
$14.24 - $14.24 $1.61 Million - $1.61 Million
113,300 New
113,300 $1.61 Million

Others Institutions Holding GRTS

About Gritstone bio, Inc.


  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $1.46M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.